All Stories

  1. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
  2. COVID-19: why did Italy decide to keep schools closed?
  3. COVID-19: are T lymphocytes simply watching?
  4. Teaching histology and anatomy online during the COVID‐19 pandemic
  5. Online lessons of human anatomy: Experiences during the COVID‐19 pandemic
  6. Effects of winter sea bathing on psychoneuroendocrinoimmunological parameters
  7. Hyper-immune/convalescent plasma: an old option and a valid strategy for treatment of COVID-19?
  8. Teaching anatomy at the time of COVID‐19
  9. FRI0480 CHANGES IN CIRCULATING SCTLA-4 FOLLOWING ZOLEDRONIC ACID INFUSION
  10. Hypothalamic expression of PD-L1: does it mediate hypothalamitis?
  11. Immune Response to Rotavirus and Gluten Sensitivity
  12. CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor
  13. Evaluation of neuroendocrine parameters during osteopathic manipulative treatment (OMT)
  14. Anti-inflammatory and stress responses after intense vs moderate judo exercise in children
  15. Cranberry polyphenols regulate in vitro human T cell responses induced by E. coli bacteria isolated from urinary infection
  16. High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis
  17. Oversecretion of Soluble CTLA-4 in Various Autoimmune Diseases Overlapping Celiac Disease
  18. Observational Study on the Occurrence of Muscle Spindles in Human Digastric and Mylohyoideus Muscles
  19. The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
  20. Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases
  21. The Role of CTLA-4 Gene Polymorphisms in Autoimmune Disease Pathogenesis: A 2012 Update
  22. A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d+ Expression
  23. Are cultured stromal cells a suitable model to study osteopathic manipulative treatment (OMT) ‘in vitro’? A first experimental approach
  24. Effects of Different Up-Dosing Regimens for Hymenoptera Venom Immunotherapy on Serum CTLA-4 and IL-10
  25. 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy
  26. CD277 an Immune Regulator of T Cell Function and Tumor Cell Recognition
  27. Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression
  28. The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
  29. Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells
  30. CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions
  31. Effect of Lentiviral Vectors on the Phenotypical and Functional Maturation of Human Dendritic Cells: Implications for Gene Therapy
  32. The Inhibitory Co-Receptors: A Way to Save from Anergy the HIVSpecific T Cells
  33. Stimulation of Human CD4+ T Lymphocytes via TLR3, TLR5 and TLR7/8 Up-Regulates Expression of Costimulatory and Modulates Proliferation
  34. The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
  35. Serum cytotoxic T lymphocyte–associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy
  36. Identification of Salmonella enterica Serovar Typhi DNA Fragments with Transcriptional Activity Under Different Growth Conditions
  37. The frequency of regulatory CD3+CD8+CD28-CD25+ T lymphocytes in human peripheral blood increases with age
  38. Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation
  39. CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis
  40. Surface density expression of the leukocyte-associated Ig-like receptor-1 is directly related to inhibition of human T-cell functions
  41. Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment
  42. Natural Analogue Peptides of an HIV-1 GP120 T-Helper Epitope Antagonize Response of GP120-Specific Human CD4 T-Cell Clones
  43. Natural Analogue Peptides of an HIV-1 GP120 T-Helper Epitope Antagonize Response of GP120-Specific Human CD4 T-Cell Clones
  44. Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein
  45. Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein
  46. AttenuatedListeria monocytogenescarrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells
  47. The use of anti-tat vector for adoptive immunotherapy of AIDS
  48. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection
  49. Human T leukaemia virus type 1 (HTLV‐1) specific T‐helper cell response: clonal fluctuations and repertoire heterogeneity
  50. Human CD4+ T Cells Can Discriminate the Molecular and Structural Context of T Epitopes of HIV gp120 and HIV p66
  51. Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies
  52. Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels
  53. Antibacterial profile of flurithromycin, a new macrolide
  54. Synergistic Antibacterial Interaction of Cefotaxime and Desacetylcefotaxime